Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCT-SR in Patients With Gastritis
NCT04189705Phase 3Completed
- Sponsor
- Otsuka Holdings
- Start
- Dec 2019
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rebamipide in gastritis, sponsored by Otsuka Holdings. Started Dec 2019; status: completed.
02
Drugs
rebamipide
03
Conditions
gastritis
Beyond the preview
Go deeper on NCT04189705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189705.